TME Pharma is a clinical-stage company focusing on developing novel therapies for treatment of the most aggressive cancers. We specialize in approaches targeting the tumor microenvironment (TME) in which cancer cells exist. Our unique technology breaks tumor protection barriers against the immune system and blocks tumor repair by neutralizing chemokines in the TME. TME Pharma’s approach works in combination with other forms of treatment to weaken tumor defenses and enable greater therapeutic impact. TME Pharma’s mission is to improve treatment outcomes for patients with cancer where TME significantly limits survival. The lead compound NOX-A12 acts in two distinct mechanisms of action, presenting great potential for developing this asset in various oncology indications. Currently, TME Pharma is focused on brain cancer (glioblastoma, GBM), with promising topline clinical results.
NOXXON's Spiegelmer® platform has generated a proprietary pipeline of clinical-stage assets including its lead cancer candidate NOX-A12, which is the subject of a clinical immuno-oncology collaboration agreement with Merck & Co. / MSD (NYSE: MRK) to study NOX-A12 combined with KEYTRUDA® (pembrolizumab) in pancreatic and colorectal cancer. NOXXON’s pipeline also contains NOX-E36, which targets other tumor microenvironment targets implicated in cancer spread and immune privilege of tumors.
Company Details
- Employees
- 15
- Founded
- -
- Address
- Max-Dohrn-Str. 8-10, Berlin,10589,germany
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- noxxon.com
- HQ
- Berlin
Tme Pharma Questions
Tme Pharma's website is noxxon.com
Tme Pharma's LinkedIn profile is https://de.linkedin.com/company/tme-pharma
Tme Pharma has
15 employees.
View email and phone details for 15
employees at Tme Pharma.
Tme Pharma's industry is
Pharmaceutical Manufacturing
Tme Pharma's top competitors are
Cellphenomics Gmbh,
Aptarion Biotech Ag,
Migentra Gmbh,
Fyonibio Gmbh,
Sphingotec,
Biogenes Gmbh,
Emp Biotech Gmbh,
3b Pharmaceuticals Gmbh,
Adrenomed Ag,
Probiogen Ag.
Tme Pharma's categories are Pharmaceutical Manufacturing
Tme Pharma's founding year is 1998
